Alpha Lipoic Acid Influence in the Attenuation of Oxidative Stress and of Clinical Manifestations of Neuropathy in Diabetes Mellitus Patients

1. Bansal, V, J Kalita, and U K Misra. “Diabetic Neuropathy.” Postgraduate Medical Journal 82.964 (2006): 95–100. PMC. Web. 27 June 2018.10.1136/pgmj.2005.036137Search in Google Scholar

2. Juster-Switlyk, Kelsey, and A. Gordon Smith. “Updates in Diabetic Peripheral Neuropathy.” F1000Research 5 (2016): F1000 Faculty Rev–738. PMC. Web. 27 June 2018.10.12688/f1000research.7898.1Search in Google Scholar

3. Román-Pintos, Luis Miguel et al. “Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function.” Journal of Diabetes Research 2016 (2016): 3425617. PMC. Web. 27 June 2018.10.1155/2016/3425617Search in Google Scholar

4. Antonio Ayala, Mario F. Muñoz, and Sandro Argüelles, “Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 360438, 31 pages, 201410.1155/2014/360438406672224999379Search in Google Scholar

5. Mahreen, Rashida et al. “Significantly Increased Levels of Serum Malonaldehyde in Type 2 Diabetics with Myocardial Infarction.” International Journal of Diabetes in Developing Countries 30.1 (2010): 49–51. PMC. Web. 27 June 2018.10.4103/0973-3930.60006Search in Google Scholar

6. Shay, Kate Petersen et al. “Alpha-Lipoic Acid as a Dietary Supplement: Molecular Mechanisms and Therapeutic Potential.” Biochimica et biophysica acta 1790.10 (2009): 1149–1160. PMC. Web. 27 June 2018.10.1016/j.bbagen.2009.07.026Search in Google Scholar

7. Vallianou, Natalia, Angelos Evangelopoulos, and Pavlos Koutalas. “Alpha-Lipoic Acid and Diabetic Neuropathy.” The Review of Diabetic Studies : RDS 6.4 (2009): 230–236. PMC. Web. 30 June 2018.10.1900/RDS.2009.6.230Search in Google Scholar

8. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M. et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy. The SYDNEY 2 trial. Diabetes Care. 2006;29:2365–2370.1706566910.2337/dc06-121617065669Search in Google Scholar

9. Mijnhout GS, Alkhalaf A, Kleefstra N, Bilo HJ, Alpha lipoic acid: a new treatment for neuropathic pain in patients with diabetes?, Neth J Med. 2010 Apr;68(4):158-62.20421656Search in Google Scholar